Primary Record
LY2109761
- In stock
- 2,378 g
- Purity
- 98.2 %
- CAS
- 700874-71-1
Compound Identifiers & Properties
- CAS
- 700874-71-1
- PubChem CID
- 11655119
- SMILES
- C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6
- Canonical SMILES
- c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1
Names & Synonyms
- LY2109761
- 700874-71-1
- STREPTOZOTOCIN
- DV3HD37UBK
- LY-2109761
- LY 2109761
- RefChem:925055
- UNII-DV3HD37UBK
- D06KKN
- Dihydropyrrolopyrazole, 15d
- cc-120
- MLS006010968
- DTXSID30470111
- 4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine
- IHLVSLOZUHKNMQ-UHFFFAOYSA-N
- MFCD12923354
- C26H27N5O2
- CHEMBL260015
- GTPL8075
- orb1306433
- SCHEMBL3737735
- SCHEMBL30611591
- BDBM21509
- KS-00000XPQ
- DTXCID80420929
- EX-A071
- GLXC-03265
- HMS3674E17
- AMY24227
- BCP02824
- ABP001002
- NSC765632
- s2704
- ZINC14976393
- AKOS022183732
- BCP9000868
- CCG-269143
- CS-0571
- NSC-765632
- QC-7261
- RL04685
- SB19481
- CID11655119
- NCGC00242598-01
- NCGC00242598-03
- NCGC00242598-10
- 4CA-0771
- AC-30289
- AJ-65535
- AK-83152
- AS-56101
- BC635842
- CID:11655119
- HY-12075
- SC-86319
- SMR004702772
- SID:223438197
- AB0008023
- DB-349029
- A8464
- FT-0698866
- ST24042818
- Y0460
- J3.492.331K
- A11133
- W-5549
- A853576
- C530108
- BRD-K47557313-001-02-7
- LY2109761,CAS:700874-71-1
- Q27082613
- B2693-286403
- 4-[2-[4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]oxyethyl]morpholine
- 700874-71-1 pound not LY-2109761 pound not LY 2109761
- 4-(2-(4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
- 4-(5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-7-(2-(4-morpholinyl)ethoxy)quinoline
- 4-[5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]-quinoline
- 4-[5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]quinoline
- 7-[2-(MORPHOLIN-4-YL)ETHOXY]-4-[2-(PYRIDIN-2-YL)-4H,5H,6H-PYRROLO[1,2-B]PYRAZOL-3-YL]QUINOLINE
- Quinoline, 4-(5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-7-(2-(4-morpholinyl)ethoxy)-
- 18883-66-4
- 4-(2-(4-(2-(pyridin-2-yl)-3a,4,5,6-tetrahydro-3H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yloxy)ethyl)morpholine
- 4-[2-({4-[2-(pyridin-2-yl)-4H,5H,6H-pyrrolo[1,2-a]pyrazol-3-yl]quinolin-7-yl}oxy)ethyl]morpholine
- 4-[2-[[4-[2-(2-pyridyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-quinolyl]oxy]ethyl]morpholine
- 4-[2-[4-(2-Pyridin-2-yl-5,6-dihydro-4H-pyrrolo[2,1-e]pyrazol-3-yl)quinolin-7-yl]oxyethyl]morpholine
- 7-(2-morpholin-4-yl-ethoxy)-4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)-quinoline
- 7-(2-morpholin-4-ylethoxy)-4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo(2,1-e)pyrazol-3-yl)quinoline
- 7-(2-morpholin-4-ylethoxy)-4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[2,1-e]pyrazol-3-yl)quinoline
- 7-(2-morpholin-4-ylethoxy)-4-(7-pyridin-2-yl-1,8-diazabicyclo[3.3.0]octa-5,7-dien-6-yl)quinoline
- 7-(2-Morpholinoethoxy)-4-(2-(pyridine-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole-3-yl)quinoline
- 7-[2-(Morpholin-4-yl)ethoxy]-4-[2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline
- LY2109761, 98%, a novel selective TGF-beta receptor type I/II (TbetaRI/II) dual inhibitor - 25MG 25mg
- Quinoline, 4-[5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]-